Vertex Pharmaceuticals
Bart B. has extensive experience in clinical and quantitative pharmacology, currently serving as Associate Director at Vertex Pharmaceuticals since September 2016. Notable contributions include leading quantitative pharmacology efforts in Cystic Fibrosis research, managing stakeholder analyses for regulatory interactions, and supporting post-authorization commitments for TRIKAFTA. Previously, Bart held roles as Senior Scientist and Scientist II, leading pharmacodynamic analyses for CRISPR gene therapy and ensuring pediatric dose selection for SYMDEKO. Bart's academic background includes a Ph.D. in Physiology and Bioinformatics from McGill University and an Honours Bachelor of Science from the University of Toronto, complemented by teaching roles and research experience in mathematical modeling of biological systems.
This person is not in any teams
This person is not in any offices
Vertex Pharmaceuticals
87 followers
Vertex Pharmaceuticals is focused on the discovery and development of small molecule drugs for the treatment of serious diseases.